Stocks to Sell

Stocks can plunge for any number of reasons — investors may need to raise cash for large milestone purchases, or algorithms could be triggered by stop losses which create massive selloffs. Whatever the case, InvestorPlace’s journalists weed out the markets’ losers, keeping you informed of which stocks to cash out of before they come crashing down.

The Smart Money: Sears Holdings Corp (SHLD) Is Already Insolvent

By James Brumley, InvestorPlace Feature Writer
Sears (SHLD) is running out of cash fast. Worse: Credit default swap prices say the troubled retailer will default in less than two years.

4 Energy Stocks That Are Ticking Time Bombs

By Anthony Mirhaydari, InvestorPlace Market Strategist
U.S. equities are drifting higher on Tuesday, yet nervousness remains among basic materials, energy and financial stocks.

Whole Foods Market, Inc. (WFM): A Basket of Problems With No Answers

By Lawrence Meyers, InvestorPlace Contributor
Whole Foods (WFM) reports fiscal Q1 earnings on Wednesday, but what WFM stock holders need for a resurgence ... they won't get.

DryShips Inc. (DRYS) Stock Could Sink Further on Waves of Uncertainty

By Richard Saintvilus, InvestorPlace Contributor
DryShips (DRYS) has roughly tripled in a couple weeks, but despite the appeal of riding a massive rebound, investors should avoid DRYS stock.

Michael Kors Holdings Ltd (KORS) Stock Crumples on Weak Q4 Outlook

By Richard Saintvilus, InvestorPlace Contributor
Michael Kors (KORS) investors were caught holding the bag Tuesday on a guidance miss. A 15% discount doesn't make KORS stock look any better.

Under Armour Inc (UA) Bit Off Way More Than It Can Chew

By Josh Enomoto, InvestorPlace Contributor
Sure, UA stock is backed by a strong brand name and gutsy marketing, but Under Armour is still at a huge disadvantage against the big boys.

7 Stocks That Will Drop by 10% or More This Quarter

By Johnson Research Group
This bull market won't crash into a wall, but a number of stocks have simply run out of gas. Get out before the double-digit declines begin.

Exxon Mobil Corporation (XOM) Stock’s Q4 Earnings Miss Was Priced In

By Chris Fraley, InvestorPlace Contributor
Exxon Mobil just reported its worst quarterly earnings results in 17 years, but the damage to XOM stock has been limited. Is it time to buy?

Here’s What to Expect From Goodyear Tire & Rubber Co (GT) Earnings

By
The Goodyear Tire & Rubber (GT) is set to report fourth-quarter and full-year 2016 results on Feb 8. Here's what investors can expect

General Electric Company (GE) Stock Isn’t Worth the 3.2% Yield

By Will Ashworth, InvestorPlace Contributor
General Electric’s (GE) 3.2% yield is attractive, but there are options other than GE stock that will get the job done -- and better.

Why Sprint Corp (S) Stock Can’t Escape the Rocky Road Ahead

By James Brumley, InvestorPlace Feature Writer
Current owners of Sprint stock may want to get out now, while they can do so at a decent price. The turnaround effort has barely made a dent.

Should You Buy FireEye Inc (FEYE) Stock? 3 Pros, 3 Cons

By Ian Bezek, InvestorPlace Contributor
FireEye (FEYE) reported mounting losses and slowing revenue growth in Q4. Can FEYE stock turn the corner, or should dip-buyers steer clear?

2 Reasons Ford Motor Company (F) Stock Is Tough to Own Now

By James Brumley, InvestorPlace Feature Writer
Ford Motor Company doesn't need any more headwinds, but shares of F stock are going to be dealing with two big ones all the same.

7 Stocks to Sell as Fear Returns to the Market

By Anthony Mirhaydari, InvestorPlace Market Strategist
These seven stocks to sell are setting up as potential losers amid an overbought market, cracking stock charts and unfavorable seasonality.

Whole Foods Market, Inc. (WFM) Stock Isn’t As Tasty It Looks

By Josh Enomoto, InvestorPlace Contributor
WFM stock has been taken well below its all-time highs. However, speculating on Whole Foods now could still be a risky move.

Valeant Pharmaceuticals Intl Inc (VRX) Has Only a Little Time Left

By Vince Martin, InvestorPlace Contributor
Valeant Pharmaceuticals' debt load appears manageable -- until 2020 when major debt payments come due, and that year could possibly mark the end of Valeant Pharmaceuticals

Biogen Inc (BIIB) Stock Needs a Biotech Bounceback

By Chris Fraley, InvestorPlace Contributor
Biogen just beat fourth-quarter earnings. But BIIB stock won't really get going until the biotech sector as a whole does.

3 Reasons to Steer Clear of Groupon Inc (GRPN) Stock

By Marie Brodbeck, InvestorPlace Contributor
Groupon's (GRPN) fierce competition and lackluster turnaround story make GRPN stock a risky buy that investors should avoid.

3 Reverse Stock Splits That Could Be Ticking Time Bombs

By Wayne Duggan, InvestorPlace Contributor
DRYS, CTIC and SPRT all have businesses that are headed in the wrong direction, and more reverse stock splits is not the answer.
Load More Articles